|
Synonyms: Krystexxa® | puricase
pegloticase is an approved drug (FDA (2010), EMA (2013))
Compound class:
Peptide or derivative
Comment: Pegloticase is a porcine-like recombinant uricase, which is PEGylated to increase its biological half-life. The peptide sequence for the enzyme monomer is available in the ChEMBL entry. The enzyme is a tetramer, and lysine residues are PEGylated.
|
| No information available. |
Summary of Clinical Use  |
| Used to treat chronic gout. |
| Mechanism Of Action and Pharmacodynamic Effects |
| The uricase activity of the drug converts uric acid to allantoin. Allantoin is more soluble than uric acid and is less likely to crystallise. |
| External links |
|
For extended ADME data see the following: Drugs.com European Medicines Agency (EMA) |
